Digital Health Research

Global Digital Health Funding and Key Trends 2025: Re-priced, Re-proved, Re-focused

Report access and advisory support are available through Galen Growth.

In 2025, capital snapped back only for real performers—ventures proving adoption, unit economics, and execution. Health systems tightened the rules, demanding workflow fit and ROI. Evidence, interoperability, and distribution now separate contenders from pretenders as the market reopens, raising the stakes for anyone who can’t deliver measurable value.

Re-priced. Re-proved. Re-focused.

2025 was the year digital health re-priced and re-proved itself.

The easy money era is over, and the ecosystem has emerged from the funding winter more disciplined and selective. Capital is now flowing to teams that can demonstrate adoption, durable economics, and execution at scale. Health systems tightened the rules, demanding workflow fit and measurable ROI, forcing ventures to prove real-world impact—not hype. Evidence and distribution became the new power metrics, separating true operators from storytellers.

As the exits window begins to reopen, the winners are clearer than ever—and so are the consequences for anyone who can’t deliver.

For investors, the report shows how risk has shifted decisively toward venture execution. For pharma leaders, it highlights an ecosystem consolidating around fewer, higher-confidence partners in core categories. For health systems and hospitals, it is a clear signal to seize the momentum for change. And for innovators, it clarifies what the market now values most: evidence, interoperability, and measurable value creation.

Powered by HealthTech Alpha’s billion-plus data points, this report delivers a definitive retrospective on the global digital health ecosystem in 2025 and provides practical guidance for navigating the path forward.

Report Highlights

  • Capital concentrated into ventures with proven performance and real-world impact

  • Deal sizes rose in 2025, signalling stronger investor conviction in high-quality opportunities

  • Health systems increasingly shaped innovation through workflow and ROI requirements

  • Mega-deals continued to dominate, with large rounds accounting for nearly half of all capital deployed

  • M&A activity remained measured as fundraising rebounded and early signs of public-market reopening emerged

Ventures and Companies Covered in the Report

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com

Page Description Content
2-4 Foreword & Key Takeaways
9-19 Hype to Hard Results 8 charts, 3 tables
20-28 Exits & 2026 Outlook 3 charts, 3 tables
29-36 Ecosystem Insights 11 charts, 1 table
37-52 Investment Insights 32 charts, 3 tables
53-60 Cluster Focus 4 charts, 2 tables
61-66 Therapeutic Focus 4 charts, 2 tables
67-84 Regional Snapshots United States (p.69), Europe (p.74), Asia Pacific (p.79); 15 charts, 3 tables
85-88 Key Information

Full access

Need full access to this research?

Contact Galen Growth to discuss full report access, advisory support, and HealthTech Alpha intelligence for your team. We will help you identify the right level of research access for your organization.

  • Full report access and downloadable research
  • HealthTech Alpha digital health intelligence
  • Advisory support for market, funding, and ecosystem analysis
Contact us for full access

Research context

Global Digital Health Funding and Key Trends 2025: Re-priced, Re-proved, Re-focused for digital health decision-makers

This research supports healthtech, digital health, investment, and healthcare innovation teams with structured market intelligence from Galen Growth and HealthTech Alpha.

Overview

Category

Stage

Total Funding

GGA Score

powered by